Rough operators: sphingomyelinase inhibitors spike NK cells to kill cancer

Signal Transduct Target Ther. 2023 Aug 21;8(1):316. doi: 10.1038/s41392-023-01550-0.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Killer Cells, Natural
  • Neoplasms* / drug therapy
  • Neoplasms* / genetics
  • Sphingomyelin Phosphodiesterase* / genetics

Substances

  • Sphingomyelin Phosphodiesterase